Glitipni: A phase 1b clinical trial combining surgical resection with direct intracerebral injection of immune checkpoint inhibitors in patients with recurrent glioblastoma

Authors
Category Primary study
JournalNeuro-Oncology
Year 2019
This article has no abstract
Epistemonikos ID: 44a094fafc1024d216e7288df2e8295a8b9343c7
First added on: Feb 11, 2025